NCT07043608 2025-07-02ZAMBONIUniversity of California, San FranciscoPhase 2 Not yet recruiting20 enrolled
NCT01215344 2018-05-15First Autologous Transplant on Minimal Residual Disease Markers in Previously Untreated Myeloma Undergoing Initial Treatment With VelcadeVanderbilt-Ingram Cancer CenterPhase 2 Completed36 enrolled 8 charts
NCT00222053 2010-04-02IFM 99-02 Thalidomide in MyelomaUniversity Hospital, ToulousePhase 3 Completed800 enrolled